Delivering high-quality and affordable care throughout the cancer care continuum.

Ya Chen Tina Shih, Patricia A. Ganz, Denise Aberle, Amy Abernethy, Justin Bekelman, Otis Brawley, James Goodwin, Jim C. Hu, Deborah Schrag, Jennifer S. Temel, Lowell Schnipper

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The national cost of cancer care is projected to reach $173 billion by 2020, increasing from $125 billion in 2010. This steep upward cost trajectory has placed enormous an financial burden on patients, their families, and society as a whole and raised major concern about the ability of the health care system to provide and sustain high-quality cancer care. To better understand the cost drivers of cancer care and explore approaches that will mitigate the problem, the National Cancer Policy Forum of the Institute of Medicine held a workshop entitled "Delivering Affordable Cancer Care in the 21st Century" in October 2012. Workshop participants included bioethicists, health economists, primary care physicians, and medical, surgical, and radiation oncologists, from both academic and community settings. All speakers expressed a sense of urgency about the affordability of cancer care resulting from the future demographic trend as well as the high cost of emerging cancer therapies and rapid diffusion of new technologies in the absence to evidence indicating improved outcomes for patients. This article is our summary of presentations at the workshop that highlighted the overuse and underuse of screening, treatments, and technologies throughout the cancer care continuum in oncology practice in the United States.

Original languageEnglish (US)
Pages (from-to)4151-4157
Number of pages7
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Volume31
Issue number32
StatePublished - Nov 10 2013

Fingerprint

Continuity of Patient Care
Quality of Health Care
Neoplasms
Costs and Cost Analysis
Education
Ethicists
Technology
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Aptitude
Primary Care Physicians
Demography
Delivery of Health Care
Health
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Shih, Y. C. T., Ganz, P. A., Aberle, D., Abernethy, A., Bekelman, J., Brawley, O., ... Schnipper, L. (2013). Delivering high-quality and affordable care throughout the cancer care continuum. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(32), 4151-4157.

Delivering high-quality and affordable care throughout the cancer care continuum. / Shih, Ya Chen Tina; Ganz, Patricia A.; Aberle, Denise; Abernethy, Amy; Bekelman, Justin; Brawley, Otis; Goodwin, James; Hu, Jim C.; Schrag, Deborah; Temel, Jennifer S.; Schnipper, Lowell.

In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 31, No. 32, 10.11.2013, p. 4151-4157.

Research output: Contribution to journalArticle

Shih, YCT, Ganz, PA, Aberle, D, Abernethy, A, Bekelman, J, Brawley, O, Goodwin, J, Hu, JC, Schrag, D, Temel, JS & Schnipper, L 2013, 'Delivering high-quality and affordable care throughout the cancer care continuum.', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 31, no. 32, pp. 4151-4157.
Shih, Ya Chen Tina ; Ganz, Patricia A. ; Aberle, Denise ; Abernethy, Amy ; Bekelman, Justin ; Brawley, Otis ; Goodwin, James ; Hu, Jim C. ; Schrag, Deborah ; Temel, Jennifer S. ; Schnipper, Lowell. / Delivering high-quality and affordable care throughout the cancer care continuum. In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 ; Vol. 31, No. 32. pp. 4151-4157.
@article{cba83a2438af465793131417c5e25f5f,
title = "Delivering high-quality and affordable care throughout the cancer care continuum.",
abstract = "The national cost of cancer care is projected to reach $173 billion by 2020, increasing from $125 billion in 2010. This steep upward cost trajectory has placed enormous an financial burden on patients, their families, and society as a whole and raised major concern about the ability of the health care system to provide and sustain high-quality cancer care. To better understand the cost drivers of cancer care and explore approaches that will mitigate the problem, the National Cancer Policy Forum of the Institute of Medicine held a workshop entitled {"}Delivering Affordable Cancer Care in the 21st Century{"} in October 2012. Workshop participants included bioethicists, health economists, primary care physicians, and medical, surgical, and radiation oncologists, from both academic and community settings. All speakers expressed a sense of urgency about the affordability of cancer care resulting from the future demographic trend as well as the high cost of emerging cancer therapies and rapid diffusion of new technologies in the absence to evidence indicating improved outcomes for patients. This article is our summary of presentations at the workshop that highlighted the overuse and underuse of screening, treatments, and technologies throughout the cancer care continuum in oncology practice in the United States.",
author = "Shih, {Ya Chen Tina} and Ganz, {Patricia A.} and Denise Aberle and Amy Abernethy and Justin Bekelman and Otis Brawley and James Goodwin and Hu, {Jim C.} and Deborah Schrag and Temel, {Jennifer S.} and Lowell Schnipper",
year = "2013",
month = "11",
day = "10",
language = "English (US)",
volume = "31",
pages = "4151--4157",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "32",

}

TY - JOUR

T1 - Delivering high-quality and affordable care throughout the cancer care continuum.

AU - Shih, Ya Chen Tina

AU - Ganz, Patricia A.

AU - Aberle, Denise

AU - Abernethy, Amy

AU - Bekelman, Justin

AU - Brawley, Otis

AU - Goodwin, James

AU - Hu, Jim C.

AU - Schrag, Deborah

AU - Temel, Jennifer S.

AU - Schnipper, Lowell

PY - 2013/11/10

Y1 - 2013/11/10

N2 - The national cost of cancer care is projected to reach $173 billion by 2020, increasing from $125 billion in 2010. This steep upward cost trajectory has placed enormous an financial burden on patients, their families, and society as a whole and raised major concern about the ability of the health care system to provide and sustain high-quality cancer care. To better understand the cost drivers of cancer care and explore approaches that will mitigate the problem, the National Cancer Policy Forum of the Institute of Medicine held a workshop entitled "Delivering Affordable Cancer Care in the 21st Century" in October 2012. Workshop participants included bioethicists, health economists, primary care physicians, and medical, surgical, and radiation oncologists, from both academic and community settings. All speakers expressed a sense of urgency about the affordability of cancer care resulting from the future demographic trend as well as the high cost of emerging cancer therapies and rapid diffusion of new technologies in the absence to evidence indicating improved outcomes for patients. This article is our summary of presentations at the workshop that highlighted the overuse and underuse of screening, treatments, and technologies throughout the cancer care continuum in oncology practice in the United States.

AB - The national cost of cancer care is projected to reach $173 billion by 2020, increasing from $125 billion in 2010. This steep upward cost trajectory has placed enormous an financial burden on patients, their families, and society as a whole and raised major concern about the ability of the health care system to provide and sustain high-quality cancer care. To better understand the cost drivers of cancer care and explore approaches that will mitigate the problem, the National Cancer Policy Forum of the Institute of Medicine held a workshop entitled "Delivering Affordable Cancer Care in the 21st Century" in October 2012. Workshop participants included bioethicists, health economists, primary care physicians, and medical, surgical, and radiation oncologists, from both academic and community settings. All speakers expressed a sense of urgency about the affordability of cancer care resulting from the future demographic trend as well as the high cost of emerging cancer therapies and rapid diffusion of new technologies in the absence to evidence indicating improved outcomes for patients. This article is our summary of presentations at the workshop that highlighted the overuse and underuse of screening, treatments, and technologies throughout the cancer care continuum in oncology practice in the United States.

UR - http://www.scopus.com/inward/record.url?scp=84891686782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891686782&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 4151

EP - 4157

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 32

ER -